GONORRHEA DIAGNOSTIC MARKET ANALYSIS

Market News

Key Developments

1. Major companies in the market are focused on various business strategies such as gaining approval from regulatory authorities, in order to provide better diagnostic solutions for gonorrhea. For instance, in August 2019, binx health received the U.S. Food and Drug Administration (FDA) 510 (k) clearance for its rapid point of care platform binx io. The binx io platform is used for detection of gonorrhea and chlamydia.
2. Major companies in the market are focused on various business strategies such as gaining approval from regulatory authorities, in order to provide better diagnostic solutions for gonorrhea. For instance, in May 2019, Hologic, Inc. received the U.S. FDA 510 (k) approval for its gonorrhea and chlamydia diagnostic test Aptima Combo 2 Assays. It is one of the first testing devices cleared for testing of these sexually transmitted diseases.
3. Major companies in the market are focused on various business strategies such as gaining approval from regulatory authorities, in order to provide better diagnostic solutions for gonorrhea. For instance, in May 2019, Cepheid, Inc. received the U.S. FDA 510 (k) clearance for testing rectal and throat specimens with Xpert CT/NG test. This devices provide accurate detection of gonorrhea and chlamydia.